Clinical trial
Radiation Therapy Plus Paclitaxel in Treating Patients With Nonmetastatic…
NCT00003591 · Radiation Therapy Oncology Group, Other · Completed
Key facts
| NCT number | NCT00003591 |
|---|---|
| Title | Radiation Therapy Plus Paclitaxel in Treating Patients With Nonmetastatic, Unresectable Pancreatic Cancer |
| Official title | A Phase II Trial of External Irradiation (50.4 GY) and Weekly Paclitaxel (Taxol) for Non-Metastatic, Unresectable Pancreatic Cancer |
| Lead sponsor | Radiation Therapy Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Pancreatic Cancer |
| Intervention type | Drug, Radiation |
| Interventions | paclitaxel, radiation therapy |
| Enrollment | 122 |
| Start date | Nov 1, 1998 |
| Primary completion | Jun 1, 2001 |
| Completion | Oct 1, 2005 |
| First posted | Sep 13, 2004 |
| Last update posted | Nov 13, 2013 |
| Countries | Canada, United States |
At a glance
- 100–999 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: